Posts

New research by Sylvester Cancer shows unmet support ne...

MIAMI, FLORIDA (June 27, 2023) – Cancer patients with unmet supportive care need...

Move over diamond. hBN is quantum’s new best friend.

Diamond has long been the go-to material for quantum sensing due to its coherent...

Synthesis of peripherally annulated phenanthroporphyrins

Prof. Okujima, in collaboration with Prof. Kobayashi at Shinshu University, repo...

Recent progress of Ni-based catalysts for methanol elec...

The study is led by Ligang Feng (School of Chemistry and Chemical Engineering, Y...

Pfizer’s Talzenna gets wider approval for prostate canc...

Pfizer’s Talzenna has received FDA approval as a second PARP inhibitor for prost...

Union study for oral orismilast yields positive results...

A recent Phase 2 study conducted by Union Therapeutics has yielded positive resu...

ACIP Panel Set to Vote For Use of New GSK and Pfizer RS...

The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disea...

How abortion access changed in the first year after Roe...

How abortion access changed in the first year after Roe v. Wade, in 8 charts.

Does DIY still have a place in diabetes care? 

When Dana Lewis built her first artificial pancreas in 2014, she — and millions ...

STAT+: Two type 1 diabetes patients now freed from insu...

With two Type 1 diabetes patients now successfully treated, Vertex says it’s rea...

STAT+: Lilly’s obesity pill cuts 15% of weight at highe...

A pill under development by Lilly could offer weight loss benefits in parts of t...

In absence of Roe v. Wade, an abortion doctor dwells on...

“I actually want people to be less 'careful' when they talk about abortion and l...

Opinion: Peter Hotez is not alone: Online harassment of...

Attacks on experts threaten public safety by limiting access to scientific and m...

‘We fail people’: New data on disparities in Medicaid a...

Overall, the study found that 55% of Medicaid enrollees with opioid addiction re...

STAT+: Pharmalittle: FDA approves first gene therapy fo...

The states of California, New York, Illinois, Minnesota, Washington, and Wiscons...

STAT+: EU poised to reject Amylyx’s ALS drug, as the co...

European regulators are on the verge of rejecting an ALS drug from Amylyx Pharma...